(MENAFN- Nxtgen Reports) Heparin, also known as unfractionated heparin (UFH), is medication which is used as an anticoagulant (blood thinner). Specifically it is used to treat and prevent deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It is also used in the treatment of heart attacks and unstable angina.[3] It is given by injection into a vein.Other uses include inside test tubes and kidney dialysis machines.Common side effects include bleeding, pain at the injection site, and low blood platelets.Serious side effects include heparin induced thrombocytopenia. Greater care is needed in those with poor kidney function.Heparin appears to be relatively safe for use during pregnancy and breastfeeding.Heparin is a naturally occurring glycosaminoglycan.
The Sodium Heparin market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Sodium Heparin industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Sodium Heparin market can be split based on product types, major applications, and important countries as follows:
Key players in the global Sodium Heparin market covered in Chapter 12:
Pfizer
Changshan Pharm
Opocrin
Aspen Oss
Hepalink
Qianhong Bio-pharma
In Chapter 4 and 14.1, on the basis of types, the Sodium Heparin market from 2015 to 2025 is primarily split into:
Heparin Sodium
Heparin Calcium
Other
In Chapter 5 and 14.2, on the basis of applications, the Sodium Heparin market from 2015 to 2025 covers:
UFH
LMWH
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
MENAFN14052022004360009250ID1104211587
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.